During the last session, Agenus Inc (NASDAQ:AGEN)’s traded shares were 0.37 million, with the beta value of the company hitting 1.33. At the end of the trading day, the stock’s price was $3.57, reflecting an intraday loss of -5.05% or -$0.19. The 52-week high for the AGEN share is $19.69, that puts it down -451.54 from that peak though still a striking 29.97% gain since the share price plummeted to a 52-week low of $2.50. The company’s market capitalization is $83.75M, and the average intraday trading volume over the past 10 days was 0.42 million shares, and the average trade volume was 528.41K shares over the past three months.
Agenus Inc (AGEN) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.60. AGEN has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -2.64.
Agenus Inc (NASDAQ:AGEN) trade information
Agenus Inc (AGEN) registered a -5.05% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -5.05% in intraday trading to $3.57, hitting a weekly high. The stock’s 5-day price performance is 13.33%, and it has moved by 26.15% in 30 days. Based on these gigs, the overall price performance for the year is -70.15%. The short interest in Agenus Inc (NASDAQ:AGEN) is 2.95 million shares and it means that shorts have 6.07 day(s) to cover.
The consensus price target of analysts on Wall Street is $7, which implies an increase of 49.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7 and $7 respectively. As a result, AGEN is trading at a discount of -96.08% off the target high and -96.08% off the low.
Agenus Inc (AGEN) estimates and forecasts
Statistics show that Agenus Inc has underperformed its competitors in share price, compared to the industry in which it operates. Agenus Inc (AGEN) shares have gone down -41.76% during the last six months, with a year-to-date growth rate less than the industry average at 6.96% against 16.50. In the rating firms’ projections, revenue will decrease -30.82% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 31.81M as predicted by 5 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 16.95M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 83.8M and 28M respectively. In this case, analysts expect current quarter sales to shrink by -62.04% and then drop by -39.48% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 13.79%. While earnings are projected to return 11.83% in 2025, the next five years will return 23.54% per annum.
AGEN Dividends
Agenus Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Agenus Inc (NASDAQ:AGEN)’s Major holders
Agenus Inc insiders own 1.34% of total outstanding shares while institutional holders control 37.10%, with the float percentage being 37.61%. VANGUARD GROUP INC is the largest shareholder of the company, while 133.0 institutions own stock in it. As of 2024-06-30, the company held over 2.15 million shares (or 10.2305% of all shares), a total value of $36.09 million in shares.
The next largest institutional holding, with 1.55 million shares, is of BLACKROCK INC.’s that is approximately 7.6005% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $25.93 million.
Also, the Mutual Funds coming in first place with the largest holdings of Agenus Inc (AGEN) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 654.9 shares. This amounts to just over 2.79 percent of the company’s overall shares, with a $2.34 million market value. The same data shows that the other fund manager holds slightly less at 523.98, or about 2.23% of the stock, which is worth about $1.87 million.
